Skip to main content
. Author manuscript; available in PMC: 2024 Feb 4.
Published in final edited form as: Surgery. 2023 Nov 15;175(1):114–120. doi: 10.1016/j.surg.2023.06.052

Table III.

Preoperative diagnoses and procedure types for 3-group comparison

Control (N = 479) ERAS 0–2 (N = 94) ERAS 3–4 (N = 72) P value

Preoperative diagnosis, n (%)
 Graves’ 23 (4.8) 6 (6.4) 5 (6.9) .011
 MNG 58 (12.1) 8 (8.5) 0 (0.0)
 Multiple diagnoses 22 (4.6) 5 (5.3) 2 (2.8)
 Parathyroid carcinoma 2 (0.4) 0 (0.0) 0 (0.0)
 PHPT 208 (43.5) 36 (38.3) 44 (61.1)
 THPT 1 (0.2) 0 (0.0) 0 (0.0)
 Thyroid cancer 68 (14.2) 21 (22.3) 14 (19.4)
 Thyroid cyst 0 (0.0) 1 (1.1) 1 (1.4)
 Thyroid nodule 96 (20.1) 17 (18.1) 6 (8.3)
Procedure, n (%)
 Minimally invasive parathyroidectomy 128 (26.7) 26 (27.7) 39 (54.2) < .001
 Multiple procedures 23 (4.8) 3 (3.2) 6 (8.3)
 Partial thyroidectomy 109 (22.8) 35 (37.2) 15 (20.8)
 Re-do parathyroid surgery 15 (3.1) 1 (1.1) 0 (0.0)
 Re-do thyroid surgery 20 (4.2) 4 (4.3) 2 (2.8)
 Subtotal parathyroidectomy 63 (13.2) 7 (7.4) 2 (2.8)
 Total thyroidectomy 93 (19.4) 16 (17.0) 5 (6.9)
 Total thyroidectomy with CND 28 (5.8) 2 (2.1) 3 (4.2)

CND, central neck dissection; ERAS, Enhanced Recovery After Surgery; MNG, multinodular goiter; PHPT, primary hyperparathyroidism; THPT, tertiary hyperparathyroidism.